The psychological burden of cystic fibrosis

Alexandra Quittner, Estefany Saez-Flores, John D. Barton

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose of review Cystic fibrosis (CF) is the most common genetic, life-shortening illness among white populations. Management of the disease requires a complex, time-consuming treatment regimen. The purpose of this review is to highlight current research examining the psychological burden of CF, including psychological distress, social challenges, treatment burden, and adherence to daily treatments. Recent findings Individuals with CF and their parent caregivers report elevated symptoms of depression and anxiety. Recent international guidelines (Cystic Fibrosis Foundation and European Cystic Fibrosis Society) recommend annual screening of these symptoms using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales. Symptoms of depression have been associated with decreased adherence, lower quality of life, and higher healthcare costs. Adherence to pulmonary medications has been found to be 50% or less and decreases with age. Poor adherence has been associated with higher healthcare costs, more frequent hospitalizations, and worse quality of life. Summary Individuals with CF face unique challenges that can lead to psychological burden. Screening for these symptoms and developing effective interventions to improve adherence are the key targets for the next 5 years of research.

Original languageEnglish (US)
Pages (from-to)187-191
Number of pages5
JournalCurrent Opinion in Pulmonary Medicine
Volume22
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Cystic Fibrosis
Psychology
Health Care Costs
Quality of Life
Depression
Disease Management
Anxiety Disorders
Research
Caregivers
Hospitalization
Therapeutics
Anxiety
Guidelines
Lung
Health
Population

Keywords

  • adherence
  • cystic fibrosis
  • depression
  • health-related quality of life
  • psychological interventions

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The psychological burden of cystic fibrosis. / Quittner, Alexandra; Saez-Flores, Estefany; Barton, John D.

In: Current Opinion in Pulmonary Medicine, Vol. 22, No. 2, 01.03.2016, p. 187-191.

Research output: Contribution to journalArticle

Quittner, Alexandra ; Saez-Flores, Estefany ; Barton, John D. / The psychological burden of cystic fibrosis. In: Current Opinion in Pulmonary Medicine. 2016 ; Vol. 22, No. 2. pp. 187-191.
@article{6368f92009814261996773a2349888d8,
title = "The psychological burden of cystic fibrosis",
abstract = "Purpose of review Cystic fibrosis (CF) is the most common genetic, life-shortening illness among white populations. Management of the disease requires a complex, time-consuming treatment regimen. The purpose of this review is to highlight current research examining the psychological burden of CF, including psychological distress, social challenges, treatment burden, and adherence to daily treatments. Recent findings Individuals with CF and their parent caregivers report elevated symptoms of depression and anxiety. Recent international guidelines (Cystic Fibrosis Foundation and European Cystic Fibrosis Society) recommend annual screening of these symptoms using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales. Symptoms of depression have been associated with decreased adherence, lower quality of life, and higher healthcare costs. Adherence to pulmonary medications has been found to be 50{\%} or less and decreases with age. Poor adherence has been associated with higher healthcare costs, more frequent hospitalizations, and worse quality of life. Summary Individuals with CF face unique challenges that can lead to psychological burden. Screening for these symptoms and developing effective interventions to improve adherence are the key targets for the next 5 years of research.",
keywords = "adherence, cystic fibrosis, depression, health-related quality of life, psychological interventions",
author = "Alexandra Quittner and Estefany Saez-Flores and Barton, {John D.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1097/MCP.0000000000000244",
language = "English (US)",
volume = "22",
pages = "187--191",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The psychological burden of cystic fibrosis

AU - Quittner, Alexandra

AU - Saez-Flores, Estefany

AU - Barton, John D.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Purpose of review Cystic fibrosis (CF) is the most common genetic, life-shortening illness among white populations. Management of the disease requires a complex, time-consuming treatment regimen. The purpose of this review is to highlight current research examining the psychological burden of CF, including psychological distress, social challenges, treatment burden, and adherence to daily treatments. Recent findings Individuals with CF and their parent caregivers report elevated symptoms of depression and anxiety. Recent international guidelines (Cystic Fibrosis Foundation and European Cystic Fibrosis Society) recommend annual screening of these symptoms using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales. Symptoms of depression have been associated with decreased adherence, lower quality of life, and higher healthcare costs. Adherence to pulmonary medications has been found to be 50% or less and decreases with age. Poor adherence has been associated with higher healthcare costs, more frequent hospitalizations, and worse quality of life. Summary Individuals with CF face unique challenges that can lead to psychological burden. Screening for these symptoms and developing effective interventions to improve adherence are the key targets for the next 5 years of research.

AB - Purpose of review Cystic fibrosis (CF) is the most common genetic, life-shortening illness among white populations. Management of the disease requires a complex, time-consuming treatment regimen. The purpose of this review is to highlight current research examining the psychological burden of CF, including psychological distress, social challenges, treatment burden, and adherence to daily treatments. Recent findings Individuals with CF and their parent caregivers report elevated symptoms of depression and anxiety. Recent international guidelines (Cystic Fibrosis Foundation and European Cystic Fibrosis Society) recommend annual screening of these symptoms using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) scales. Symptoms of depression have been associated with decreased adherence, lower quality of life, and higher healthcare costs. Adherence to pulmonary medications has been found to be 50% or less and decreases with age. Poor adherence has been associated with higher healthcare costs, more frequent hospitalizations, and worse quality of life. Summary Individuals with CF face unique challenges that can lead to psychological burden. Screening for these symptoms and developing effective interventions to improve adherence are the key targets for the next 5 years of research.

KW - adherence

KW - cystic fibrosis

KW - depression

KW - health-related quality of life

KW - psychological interventions

UR - http://www.scopus.com/inward/record.url?scp=84957718886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957718886&partnerID=8YFLogxK

U2 - 10.1097/MCP.0000000000000244

DO - 10.1097/MCP.0000000000000244

M3 - Article

VL - 22

SP - 187

EP - 191

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 2

ER -